1. Burger HG,
Dudley EC, Cui J, Dennerstein L, Hopper JL. A
prospective
longitudinal study of serum testosterone, dehydroepi-
androsterone
sulfate, and sex hormone-binding globulin levels
through the
menopause transition. J Clin Endocrinol Metab. 2000;
85:2832-2838.
2. Lobo RA.
Androgens in postmenopausal women: production, pos-
sible role, and
replacement options. Obstet Gynecol Surv. 2001;56:
361-376.
3. Bachmann G,
Bancroft J, Braunstein G, et al. Female androgen
insufficiency:
the Princeton consensus statement on definition,
classification,
and assessment. Fertil Steril. 2002;77:660-665.
4. Rosner W.
Measurement of androgens: methods and pitfalls. In:
Androgens in
Women: Physiology, Deficiency, and Emerging
Therapeutic
Potentials. Chevy Chase, Md: The Endocrine Society
Continuing
Medical Education Services; 2000. Available at:
www.androgensinwomen.com.
Accessibility verified February 12,
2004.
5. Sherwin BB,
Gelfand MM, Brender W. Androgen enhances sexual
motivation in
females: a prospective, crossover study of sex steroid
administration
in the surgical menopause. Psychosom Med. 1985;
47:339-351.
6. Sherwin BB,
Gelfand MM. Differential symptom response to
parenteral
estrogen and/or androgen administration in the surgical
menopause. Am
J Obstet Gynecol. 1985;151:153-160.
7. Sherwin BB,
Gelfand MM. The role of androgen in the mainte-
nance of sexual
functioning in oophorectomized women.
Psychosom
Med. 1987;49:397-409.
8. Davis SR,
McCloud P, Strauss BJ, Burger H. Testosterone en-
hances
estradiol’s effects on postmenopausal bone density and
sexuality.
Maturitas. 1995;21:227-236.
9. Shifren JL,
Braunstein GD, Simon JA, et al. Transdermal testoster-
one treatment in
women with impaired sexual function after
oophorectomy.
N Engl J Med. 2000;343:682-688.
10.
Greene RR,
Burrill MW, Oppenheimer E, Nelson D. Conditions
modifying the
effectiveness of testosterone, testosterone pro-
prionate, and
methyl testosterone. Endocrinology. 1942;30:734-
740.
11.
Hickok LR,
Toomey C, Speroff L. A comparison of esterified
estrogens with
and without methyltestosterone: effects on endome-
trial histology
and serum lipoproteins in postmenopausal women.
Obstet
Gynecol. 1993;82:919-924.
12.
Lobo RA, Rosen
RC, Yang HM, Block B, Van Der Hoop RG.
Comparative
effects of oral esterified estrogens with and without
methyltestosterone on
endocrine profiles and dimensions of sexual
function in
postmenopausal women with hypoactive sexual desire.
Fertil
Steril. 2003;79:1341-1352.
13.
Phillips E,
Bauman C. Safety surveillance of esterified estrogens-
methyltestosterone
(Estratest and Estratest HS) replacement ther-
apy in the
United States. Clin Ther. 1997;19:1070-1084.
14.
Floter A,
Carlstrom K, von Schoultz B, Nathorst-Boos J. Adminis-
tration of
testosterone undecanoate in postmenopausal women:
effects on
androgens, estradiol, and gonadotrophins. Menopause.
2000;7:251-256.
15.
Floter A,
Nathorst-Boos J, Carlstrom K, von Schoultz B. Addition
of testosterone
to estrogen replacement therapy in oophorecto-
mized women:
effects on sexuality and well-being. Climacteric.
2002;5:357-365.
16.
Lobo RA, March
CM, Goebelsmann U, Krauss RM, Mishell DR Jr.
Subdermal
estradiol pellets following hysterectomy and oophorec-
tomy: effect
upon serum estrone, estradiol, luteinizing hormone,
follicle-stimulating
hormone, corticosteroid binding globulin-bind-
ing capacity,
testosterone-estradiol binding globulin-binding ca-
pacity, lipids,
and hot flushes. Am J Obstet Gynecol. 1980;138:714-
719.
17.
Javanbakht M,
Singh AB, Mazer NA, et al. Pharmacokinetics of a
novel
testosterone matrix transdermal system in healthy, premeno-
pausal women and
women infected with the human immunodefi-
ciency virus.
J Clin Endocrinol Metab. 2000;85:2395-2401.
18.
Mazer NA,
Shifren JL. Transdermal testosterone for women: a new
physiological
approach for androgen therapy. Obstet Gynecol Surv.
2003;58:489-500.
19.
Wang C, Berman
N, Longstreth JA, et al. Pharmacokinetics of
transdermal
testosterone gel in hypogonadal men: application of
gel at one site
versus four sites: a General Clinical Research Center
Study. J Clin
Endocrinol Metab. 2000;85:964-969.
20.
Wang C, Swedloff
RS, Iranmanesh A, et al, Testosterone Gel Study
Group.
Transdermal testosterone gel improves sexual func-
tion, mood,
muscle strength, and body composition parameters
in hypogonadal
men. J Clin Endocrinol Metab. 2000;85:2839-
2853.
21.
AndroGel
[package insert]. Deerfield, Ill: Unimed Pharmaceuti-
cals, Inc;
2002.
22.
Slater CC,
Souter I, Zhang C, Guan C, Stanczyk FZ, Mishell DR.
Pharmacokinetics
of testosterone after percutaneous gel or buccal
administration.
Fertil Steril. 2001;76:32-37.
23.
Morales AJ,
Nolan JJ, Nelson JC, Yen SS. Effects of replacement
dose of
dehydroepiandrosterone in men and women of advancing
age [published
correction appears in J Clin Endocrinol Metab.
1995;80:2799].
J Clin Endocrinol Metab. 1994;78:1360-1367.
24.
Casson PR,
Faquin LC, Stentz FB, et al. Replacement of dehydro-
epiandrosterone
enhances T-lymphocyte insulin binding in post-
menopausal
women. Fertil Steril. 1995;63:1027-1031.
25.
Barnhart KT,
Freeman E, Grisso JA, et al. The effect of dehydro-
epiandrosterone
supplementation to symptomatic perimenopausal
women on serum
endocrine profiles, lipid parameters, and health-
related quality
of life. J Clin Endocrinol Metab. 1999;84:3896-
3902.
26.
Wang C, Eyre DR,
Clark R, et al. Sublingual testosterone replace-
ment improves
muscle mass and strength, decreases bone resorp-
tion, and
increases bone formation markers in hypogonadal men—
a clinical
research center study. J Clin Endocrinol Metab. 1996;81:
3654-3662.
27.
Miles RA,
Cassidenti DL, Carmina E, Gentzschein E, Stanczyk FZ,
Lobo RA.
Cutaneous application of an androstenedione gel as an in
vivo test of 5
alpha-reductase activity in women. Fertil Steril. 1992;
58:708-712.
28.
Duffy DM, Legro
RS, Chang L, Stanczyk FZ, Lobo RA. Metabo-
lism of
dihydrotestosterone to 5 alpha-androstane-3 alpha, 17 beta-
diol glucuronide
is greater in the peripheral compartment than in
the splanchnic
compartment. Fertil Steril. 1995;64:736-739.
29.
Barrett-Connor
E, Young R, Notelovitz M, et al. A two-year,
double-blind
comparison of estrogen-androgen and conjugated es-
trogens in
surgically menopausal women: effects on bone mineral
density,
symptoms and lipid profiles. J Reprod Med. 1999;44:
1012-1020.